These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 20307839)
1. Human papillomavirus-related disease in men: not just a women's issue. Palefsky JM J Adolesc Health; 2010 Apr; 46(4 Suppl):S12-9. PubMed ID: 20307839 [TBL] [Abstract][Full Text] [Related]
2. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. Marty R; Roze S; Bresse X; Largeron N; Smith-Palmer J BMC Cancer; 2013 Jan; 13():10. PubMed ID: 23298365 [TBL] [Abstract][Full Text] [Related]
3. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented]. Kiellberg Larsen H; Kofoed K; Sand C Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705 [TBL] [Abstract][Full Text] [Related]
5. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J BMJ; 2015 May; 350():h2016. PubMed ID: 25985328 [TBL] [Abstract][Full Text] [Related]
6. Impact of prophylactic human papillomavirus vaccines on dermatology and venereology. Gross G G Ital Dermatol Venereol; 2008 Aug; 143(4):259-65. PubMed ID: 18833082 [TBL] [Abstract][Full Text] [Related]
7. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? McRee AL; Reiter PL; Chantala K; Brewer NT Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1937-44. PubMed ID: 20647398 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Giuliano AR; Tortolero-Luna G; Ferrer E; Burchell AN; de Sanjose S; Kjaer SK; Muñoz N; Schiffman M; Bosch FX Vaccine; 2008 Aug; 26 Suppl 10(0 10):K17-28. PubMed ID: 18847554 [TBL] [Abstract][Full Text] [Related]
9. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Kim JJ Lancet Infect Dis; 2010 Dec; 10(12):845-52. PubMed ID: 21051295 [TBL] [Abstract][Full Text] [Related]
10. [Human Papillomavirus infection and vaccination: knowledge and attitudes of Italian general practitioners]. Signorelli C; Odone A; Pezzetti F; Spagnoli F; Visciarelli S; Ferrari A; Camia P; Latini C; Ciorba V; Agodi A; Barchitta M; Scotti S; Misericordia P; Pasquarella C Epidemiol Prev; 2014; 38(6 Suppl 2):88-92. PubMed ID: 25759351 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccination in the United Kingdom: what about boys? Kubba T Reprod Health Matters; 2008 Nov; 16(32):97-103. PubMed ID: 19027627 [TBL] [Abstract][Full Text] [Related]
12. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions? Elst L; Albersen M Semin Oncol Nurs; 2022 Jun; 38(3):151284. PubMed ID: 35577640 [TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Park IU; Introcaso C; Dunne EF Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622 [TBL] [Abstract][Full Text] [Related]
14. Acceptability of HPV vaccines and perceptions related to genital warts and penile/anal cancers among men who have sex with men in Hong Kong. Wang Z; Mo PK; Lau JT; Lau M; Lai CH Vaccine; 2013 Sep; 31(41):4675-81. PubMed ID: 23845815 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Kreuter A; Wieland U Curr Opin Infect Dis; 2009 Apr; 22(2):109-14. PubMed ID: 19276878 [TBL] [Abstract][Full Text] [Related]
16. Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria. Boiron L; Joura E; Largeron N; Prager B; Uhart M BMC Infect Dis; 2016 Apr; 16():153. PubMed ID: 27084683 [TBL] [Abstract][Full Text] [Related]
18. EBCOG position statement: Gender neutral HPV vaccination for young adults. Verheijen RHM; Mahmood T; Donders G; Redman CWE; Wood P Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():187-189. PubMed ID: 31992466 [TBL] [Abstract][Full Text] [Related]
19. A review of clinical trials of human papillomavirus prophylactic vaccines. Schiller JT; Castellsagué X; Garland SM Vaccine; 2012 Nov; 30 Suppl 5(0 5):F123-38. PubMed ID: 23199956 [TBL] [Abstract][Full Text] [Related]
20. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]